GKOS
Price
$82.76
Change
-$4.71 (-5.38%)
Updated
Sep 12 closing price
Capitalization
4.75B
46 days until earnings call
LMAT
Price
$92.29
Change
-$1.94 (-2.06%)
Updated
Sep 12 closing price
Capitalization
2.09B
47 days until earnings call
Interact to see
Advertisement

GKOS vs LMAT

Header iconGKOS vs LMAT Comparison
Open Charts GKOS vs LMATBanner chart's image
Glaukos
Price$82.76
Change-$4.71 (-5.38%)
Volume$883.62K
Capitalization4.75B
LeMaitre Vascular
Price$92.29
Change-$1.94 (-2.06%)
Volume$77.96K
Capitalization2.09B
GKOS vs LMAT Comparison Chart in %
Loading...
GKOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LMAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GKOS vs. LMAT commentary
Sep 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GKOS is a Hold and LMAT is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 13, 2025
Stock price -- (GKOS: $82.76 vs. LMAT: $92.29)
Brand notoriety: GKOS and LMAT are both not notable
GKOS represents the Medical/Nursing Services, while LMAT is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: GKOS: 93% vs. LMAT: 49%
Market capitalization -- GKOS: $4.75B vs. LMAT: $2.09B
GKOS [@Medical/Nursing Services] is valued at $4.75B. LMAT’s [@Pharmaceuticals: Other] market capitalization is $2.09B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $230.87B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $161.2B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.65B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GKOS’s FA Score shows that 0 FA rating(s) are green whileLMAT’s FA Score has 1 green FA rating(s).

  • GKOS’s FA Score: 0 green, 5 red.
  • LMAT’s FA Score: 1 green, 4 red.
According to our system of comparison, LMAT is a better buy in the long-term than GKOS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GKOS’s TA Score shows that 5 TA indicator(s) are bullish while LMAT’s TA Score has 5 bullish TA indicator(s).

  • GKOS’s TA Score: 5 bullish, 4 bearish.
  • LMAT’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both GKOS and LMAT are a good buy in the short-term.

Price Growth

GKOS (@Medical/Nursing Services) experienced а -11.90% price change this week, while LMAT (@Pharmaceuticals: Other) price change was -5.33% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +2.34%. For the same industry, the average monthly price growth was +3.98%, and the average quarterly price growth was +29.53%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.73%. For the same industry, the average monthly price growth was +3.41%, and the average quarterly price growth was +30.20%.

Reported Earning Dates

GKOS is expected to report earnings on Oct 29, 2025.

LMAT is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Medical/Nursing Services (+2.34% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Pharmaceuticals: Other (+2.73% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GKOS($4.75B) has a higher market cap than LMAT($2.09B). LMAT YTD gains are higher at: 0.860 vs. GKOS (-44.805). LMAT has higher annual earnings (EBITDA): 73.8M vs. GKOS (-47.8M). LMAT has more cash in the bank: 319M vs. GKOS (275M). GKOS has less debt than LMAT: GKOS (105M) vs LMAT (186M). GKOS has higher revenues than LMAT: GKOS (433M) vs LMAT (235M).
GKOSLMATGKOS / LMAT
Capitalization4.75B2.09B227%
EBITDA-47.8M73.8M-65%
Gain YTD-44.8050.860-5,208%
P/E RatioN/A45.02-
Revenue433M235M184%
Total Cash275M319M86%
Total Debt105M186M56%
FUNDAMENTALS RATINGS
GKOS vs LMAT: Fundamental Ratings
GKOS
LMAT
OUTLOOK RATING
1..100
5667
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
50
Fair valued
PROFIT vs RISK RATING
1..100
6420
SMR RATING
1..100
9557
PRICE GROWTH RATING
1..100
5050
P/E GROWTH RATING
1..100
5968
SEASONALITY SCORE
1..100
n/a34

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GKOS's Valuation (50) in the Medical Specialties industry is in the same range as LMAT (50). This means that GKOS’s stock grew similarly to LMAT’s over the last 12 months.

LMAT's Profit vs Risk Rating (20) in the Medical Specialties industry is somewhat better than the same rating for GKOS (64). This means that LMAT’s stock grew somewhat faster than GKOS’s over the last 12 months.

LMAT's SMR Rating (57) in the Medical Specialties industry is somewhat better than the same rating for GKOS (95). This means that LMAT’s stock grew somewhat faster than GKOS’s over the last 12 months.

LMAT's Price Growth Rating (50) in the Medical Specialties industry is in the same range as GKOS (50). This means that LMAT’s stock grew similarly to GKOS’s over the last 12 months.

GKOS's P/E Growth Rating (59) in the Medical Specialties industry is in the same range as LMAT (68). This means that GKOS’s stock grew similarly to LMAT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GKOSLMAT
RSI
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
61%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
77%
Momentum
ODDS (%)
Bearish Trend 1 day ago
69%
Bearish Trend 1 day ago
60%
MACD
ODDS (%)
Bearish Trend 1 day ago
68%
Bearish Trend 1 day ago
58%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
69%
Bearish Trend 1 day ago
56%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
71%
Bearish Trend 1 day ago
51%
Advances
ODDS (%)
Bullish Trend 16 days ago
78%
Bullish Trend 8 days ago
73%
Declines
ODDS (%)
Bearish Trend 1 day ago
68%
Bearish Trend 3 days ago
53%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
79%
Aroon
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
72%
View a ticker or compare two or three
Interact to see
Advertisement
GKOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LMAT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GVEYX19.82N/A
N/A
GuideStone Funds Value Equity Instl
ALVCX24.11N/A
N/A
American Beacon Large Cap Value C
SASVX6.71N/A
N/A
Virtus Ceredex Small-Cap Value Eq A
FSMDX37.44N/A
N/A
Fidelity Mid Cap Index
VIOPX17.48N/A
N/A
VALIC Company I International Opps

GKOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, GKOS has been loosely correlated with ISRG. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if GKOS jumps, then ISRG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GKOS
1D Price
Change %
GKOS100%
-5.38%
ISRG - GKOS
51%
Loosely correlated
-1.35%
NTRA - GKOS
48%
Loosely correlated
-3.05%
RDNT - GKOS
48%
Loosely correlated
+0.38%
ITGR - GKOS
48%
Loosely correlated
-2.77%
DXCM - GKOS
46%
Loosely correlated
+0.29%
More

LMAT and

Correlation & Price change

A.I.dvisor indicates that over the last year, LMAT has been loosely correlated with ITGR. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if LMAT jumps, then ITGR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LMAT
1D Price
Change %
LMAT100%
-2.06%
ITGR - LMAT
48%
Loosely correlated
-2.77%
SYK - LMAT
46%
Loosely correlated
-1.40%
UFPT - LMAT
44%
Loosely correlated
-1.02%
AORT - LMAT
40%
Loosely correlated
-3.81%
RDNT - LMAT
39%
Loosely correlated
+0.38%
More